Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dick van Soolingen

Showing results (201-210 of 273) with videos related to

Pageof 28
Sort By:
The European Respiratory Journal|August 1, 2020
Use of a whole genome sequencing-based approach for <i>Mycobacterium tuberculosis</i> surveillance in Europe in 2017-2019: an ECDC pilot studyElisa Tagliani, Richard Anthony, Thomas A Kohl, et al.
Emerging Infectious Diseases|August 17, 2005
Spoligotyping and Mycobacterium tuberculosisAndrea Gori, Alessandra Bandera, Giulia Marchetti, et al.
The Journal of Antimicrobial Chemotherapy|October 16, 2010
Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosisJurriaan E M de Steenwinkel, Gerjo J de Knegt, Marian T ten Kate, et al.
The European Respiratory Journal|March 23, 2013
Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patientsMathieu S Bolhuis, Richard van Altena, Dick van Soolingen, et al.
Journal of Clinical Microbiology|November 24, 2017
A Predominant Variable-Number Tandem-Repeat Cluster of Mycobacterium tuberculosis Isolates among Asylum Seekers in the Netherlands and Denmark, Deciphered by Whole-Genome SequencingRana Jajou, Albert de Neeling, Erik Michael Rasmussen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 28, 2019
Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014Basel Karo, Anke Kohlenberg, Vahur Hollo, et al.
Thorax|January 29, 2024
Challenging the gold standard: the limitations of molecular assays for detection of <i>Mycobacterium tuberculosis</i> heteroresistanceSarah N Danchuk, Ori E Solomon, Thomas Andreas Kohl, et al.
Journal of Clinical Microbiology|August 31, 2002
Mycobacterium microti infection (vole tuberculosis) in wild rodent populationsRachel Cavanagh, Michael Begon, Malcolm Bennett, et al.
Emerging Infectious Diseases|January 1, 2009
Invasive disease caused by nontuberculous mycobacteria, TanzaniaJohn A Crump, Jakko van Ingen, Anne B Morrissey, et al.
BMC Infectious Diseases|February 8, 2014
Inventory study of non-tuberculous mycobacteria in the European UnionMarieke J van der Werf, Csaba Ködmön, Vera Katalinić-Janković, et al.
Pageof 28

Showing results (201-210 of 273) with videos related to

Sort By:
Pageof 28
The European Respiratory Journal|August 1, 2020
Use of a whole genome sequencing-based approach for <i>Mycobacterium tuberculosis</i> surveillance in Europe in 2017-2019: an ECDC pilot studyElisa Tagliani, Richard Anthony, Thomas A Kohl, et al.
Emerging Infectious Diseases|August 17, 2005
Spoligotyping and Mycobacterium tuberculosisAndrea Gori, Alessandra Bandera, Giulia Marchetti, et al.
The Journal of Antimicrobial Chemotherapy|October 16, 2010
Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosisJurriaan E M de Steenwinkel, Gerjo J de Knegt, Marian T ten Kate, et al.
The European Respiratory Journal|March 23, 2013
Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patientsMathieu S Bolhuis, Richard van Altena, Dick van Soolingen, et al.
Journal of Clinical Microbiology|November 24, 2017
A Predominant Variable-Number Tandem-Repeat Cluster of Mycobacterium tuberculosis Isolates among Asylum Seekers in the Netherlands and Denmark, Deciphered by Whole-Genome SequencingRana Jajou, Albert de Neeling, Erik Michael Rasmussen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 28, 2019
Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014Basel Karo, Anke Kohlenberg, Vahur Hollo, et al.
Thorax|January 29, 2024
Challenging the gold standard: the limitations of molecular assays for detection of <i>Mycobacterium tuberculosis</i> heteroresistanceSarah N Danchuk, Ori E Solomon, Thomas Andreas Kohl, et al.
Journal of Clinical Microbiology|August 31, 2002
Mycobacterium microti infection (vole tuberculosis) in wild rodent populationsRachel Cavanagh, Michael Begon, Malcolm Bennett, et al.
Emerging Infectious Diseases|January 1, 2009
Invasive disease caused by nontuberculous mycobacteria, TanzaniaJohn A Crump, Jakko van Ingen, Anne B Morrissey, et al.
BMC Infectious Diseases|February 8, 2014
Inventory study of non-tuberculous mycobacteria in the European UnionMarieke J van der Werf, Csaba Ködmön, Vera Katalinić-Janković, et al.
Pageof 28